Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advent Technologies A | ADN | Sep 20, 2024 | 3.14 | -7.10 |
Adverum Biotechnologies | ADVM | Sep 20, 2024 | 7.49 | -0.13 |
AdvisorShares Pure US Cannabis ETF | MSOS | Sep 20, 2024 | 6.69 | -2.48 |
Advisorshares Star Global Buy-Write ETF | VEGA | Sep 20, 2024 | 43.32 | -0.91 |
AECOM | ACM | Sep 20, 2024 | 101.19 | -0.05 |
Aegon N.V ADR | AEG | Sep 20, 2024 | 6.24 | -0.64 |
Aehr Test Systems | AEHR | Sep 20, 2024 | 12.31 | -5.16 |
Aemetis | AMTX | Sep 20, 2024 | 2.37 | -6.69 |
Aeon Biopharma | AEON | Sep 20, 2024 | 0.69 | +3.00 |
AerCap Holdings | AER | Sep 20, 2024 | 97.02 | -1.28 |
Aeries Technology | AERT | Sep 20, 2024 | 2.31 | -1.70 |
Aerospace & Defense Powershares | PPA | Sep 20, 2024 | 113.66 | +0.41 |
Aerovate Therapeutics | AVTE | Sep 20, 2024 | 1.90 | -4.04 |
AeroVironment | AVAV | Sep 20, 2024 | 182.76 | +1.71 |
AerSale | ASLE | Sep 20, 2024 | 5.32 | -2.74 |
AES | AES | Sep 20, 2024 | 18.90 | 0.00 |
Aetherium Acquisition A | GMFI | Sep 20, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Sep 20, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Sep 20, 2024 | 0.36 | -8.21 |
Aeva Technologies | AEVA | Sep 20, 2024 | 3.19 | +1.27 |
AEye A | LIDR | Sep 20, 2024 | 1.09 | -8.40 |
AFC Gamma | AFCG | Sep 20, 2024 | 10.70 | -0.47 |
Affiliated Managers Group | AMG | Sep 20, 2024 | 178.24 | -0.83 |
Affimed N.V. | AFMD | Sep 20, 2024 | 3.69 | -6.82 |
Affinity Bancshares | AFBI | Sep 20, 2024 | 21.85 | +1.49 |
Affirm A | AFRM | Sep 20, 2024 | 44.93 | -0.11 |
Aflac | AFL | Sep 20, 2024 | 107.92 | +0.05 |
Africa Index ETF Market Vectors | AFK | Sep 20, 2024 | 16.60 | -1.33 |
African Agriculture | AAGR | Sep 20, 2024 | 0.15 | -5.06 |
Afya A | AFYA | Sep 20, 2024 | 16.40 | -2.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.